Truist Financial
MRNA icon

Truist Financial’s Moderna MRNA Stock Holding History

Truist Financial’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,839
Closed -$201K – 2610
2024
Q4 		$201K Sell
4,839
-6,646
-58% -$318K ﹤0.01% 2393
2024
Q3 		$768K Sell
11,485
-7,172
-38% -$658K ﹤0.01% 1659
2024
Q2 		$2.22M Buy
18,657
+1,275
+7% +$161K ﹤0.01% 1221
2024
Q1 		$1.85M Sell
17,382
-2,332
-12% -$235K ﹤0.01% 1322
2023
Q4 		$1.96M Sell
19,714
-156
-0.8% -$13.1K ﹤0.01% 1268
2023
Q3 		$2.05M Buy
19,870
+11,718
+144% +$1.31M ﹤0.01% 1226
2023
Q2 		$990K Buy
8,152
+926
+13% +$124K ﹤0.01% 1590
2023
Q1 		$1.11M Sell
7,226
-1,591
-18% -$262K ﹤0.01% 1504
2022
Q4 		$1.58M Buy
8,817
+2,225
+34% +$364K ﹤0.01% 1317
2022
Q3 		$779K Buy
6,592
+306
+5% +$46.4K ﹤0.01% 1601
2022
Q2 		$899K Sell
6,286
-802
-11% -$115K ﹤0.01% 1606
2022
Q1 		$1.22M Sell
7,088
-33,285
-82% -$5.6M ﹤0.01% 1528
2021
Q4 		$10.3M Sell
40,373
-3,731
-8% -$1.09M 0.02% 631
2021
Q3 		$17M Sell
44,104
-10,738
-20% -$3.96M 0.03% 461
2021
Q2 		$12.9M Sell
54,842
-8,131
-13% -$1.45M 0.02% 548
2021
Q1 		$8.25M Buy
62,973
+13,934
+28% +$2.02M 0.01% 664
2020
Q4 		$5.12M Buy
49,039
+17,927
+58% +$1.81M 0.01% 804
2020
Q3 		$2.2M Buy
31,112
+26,330
+551% +$1.84M ﹤0.01% 1042
2020
Q2 		$307K Buy
+4,782
New +$262K ﹤0.01% 1937

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Truist Financial's MRNA Position: Q1 2025 in Review

Truist Financial sold out of Moderna (MRNA) in Q1 2025, closing a stake of 4,839 shares — an estimated $201K sold.

Truist Financial first reported a position in MRNA in Q2 2020 and held it in 19 quarters. The position peaked at $17M in Q3 2021. 693 funds tracked by Wall St. Rank hold MRNA as of Q1 2025.

  • Truist Financial reported no remaining Moderna position as of Q1 2025 after selling out during the quarter.
  • Truist Financial sold 4,839 Moderna shares in Q1 2025, an estimated $201K.
  • Truist Financial first reported a position in Moderna in Q2 2020 and held it in 19 quarters.
  • Truist Financial's Moderna position peaked at $17M in Q3 2021.
  • 693 funds tracked by Wall St. Rank held Moderna as of Q1 2025.

Based on Truist Financial's 13F filing for Q1 2025, filed 29 Apr 2025.